When we searched OncoLnc public database, higher expression of mRNA of IL4Rα or IL13Rα1 was significantly associated with CCRCC patients (Log-rank, IL4Rα; p < 0.001, IL13Rα1; p = 0.001) (Figure S1). The gene discussed is IL13RA1; the disease is nonpapillary renal cell carcinoma.